Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003472623 | SCV004200660 | likely pathogenic | Dilated cardiomyopathy 1GG | 2023-02-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003779109 | SCV004573366 | pathogenic | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2024-01-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln367*) in the SDHA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SDHA are known to be pathogenic (PMID: 22974104, 24781757). This variant is present in population databases (no rsID available, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with medulloblastoma (PMID: 29489754). For these reasons, this variant has been classified as Pathogenic. |